JP2008514710A - ４，５−ジヒドロ−ピラゾロ［３，４−ｃ］ピリド−２−オン類の効率的合成 - Google Patents

４，５−ジヒドロ−ピラゾロ［３，４−ｃ］ピリド−２−オン類の効率的合成 Download PDF

Info

Publication number
JP2008514710A
JP2008514710A JP2007534699A JP2007534699A JP2008514710A JP 2008514710 A JP2008514710 A JP 2008514710A JP 2007534699 A JP2007534699 A JP 2007534699A JP 2007534699 A JP2007534699 A JP 2007534699A JP 2008514710 A JP2008514710 A JP 2008514710A
Authority
JP
Japan
Prior art keywords
och
formula
compound
ring
oso
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007534699A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008514710A5 (enExample
Inventor
ボーガスロー・エム・マドリク
ニコラ・キュニエール
ダウ−ミン・シー
ルシアス・ロッサーノ
ジン・リアン
バン−チ・チェン
チャン・フイピン
ルーリン・チャオ
ワン・ベイ
アドリアン・ダヴィド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of JP2008514710A publication Critical patent/JP2008514710A/ja
Publication of JP2008514710A5 publication Critical patent/JP2008514710A5/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2007534699A 2004-09-28 2005-09-27 ４，５−ジヒドロ−ピラゾロ［３，４−ｃ］ピリド−２−オン類の効率的合成 Withdrawn JP2008514710A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US61375404P 2004-09-28 2004-09-28
US63762304P 2004-12-20 2004-12-20
US11/235,647 US7304157B2 (en) 2004-09-28 2005-09-26 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
PCT/US2005/034511 WO2006036926A2 (en) 2004-09-28 2005-09-27 Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones

Publications (2)

Publication Number Publication Date
JP2008514710A true JP2008514710A (ja) 2008-05-08
JP2008514710A5 JP2008514710A5 (enExample) 2008-11-13

Family

ID=36100112

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007534699A Withdrawn JP2008514710A (ja) 2004-09-28 2005-09-27 ４，５−ジヒドロ−ピラゾロ［３，４−ｃ］ピリド−２−オン類の効率的合成

Country Status (11)

Country Link
US (3) US7304157B2 (enExample)
EP (1) EP1805176A2 (enExample)
JP (1) JP2008514710A (enExample)
KR (1) KR20070067176A (enExample)
AU (1) AU2005289598A1 (enExample)
BR (1) BRPI0516172A (enExample)
CA (1) CA2582222A1 (enExample)
IL (1) IL182147A0 (enExample)
MX (1) MX2007003427A (enExample)
NO (1) NO20071634L (enExample)
WO (1) WO2006036926A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017530104A (ja) * 2014-09-02 2017-10-12 石薬集団中奇制薬技術（石家庄）有限公司 ピラゾロ［３，４−ｃ］ピリジン誘導体

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI331526B (en) * 2001-09-21 2010-10-11 Bristol Myers Squibb Pharma Co Lactam-containing compounds and derivatives thereof as factor xa inhibitors
TW200738672A (en) * 2001-12-10 2007-10-16 Bristol Myers Squibb Co Intermediated for the preparation of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
DE60330749D1 (de) * 2002-01-21 2010-02-11 Organon Nv Verfahren zur herstellung von 7-alpha-methylsteroide
US20060069085A1 (en) * 2004-09-28 2006-03-30 Rulin Zhao Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
US7388096B2 (en) * 2004-09-28 2008-06-17 Bristol-Myers Squibb Company Crystalline forms of a factor Xa inhibitor
BRPI0519331A2 (pt) * 2004-12-15 2009-01-20 Bristol Myers Squibb Co formas cristalina de um inibidor de fator xa
FI20070471A0 (fi) * 2007-06-13 2007-06-13 Glykos Finland Oy Ravinnelisäkompositiota

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5423698A (en) * 1994-03-30 1995-06-13 Molex Incorporated Electrical connector system for a video display tube yoke
TWI331526B (en) 2001-09-21 2010-10-11 Bristol Myers Squibb Pharma Co Lactam-containing compounds and derivatives thereof as factor xa inhibitors
HRP20080382A2 (en) 2001-09-21 2008-12-31 Bristol-Myers Squibb Company A Delaware (Usa) Corporation LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS
TW200738672A (en) 2001-12-10 2007-10-16 Bristol Myers Squibb Co Intermediated for the preparation of 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones
US20060069085A1 (en) 2004-09-28 2006-03-30 Rulin Zhao Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
US7396932B2 (en) * 2004-09-28 2008-07-08 Bristol-Myers Squibb Company Process for preparing 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
US7388096B2 (en) 2004-09-28 2008-06-17 Bristol-Myers Squibb Company Crystalline forms of a factor Xa inhibitor
US20060069260A1 (en) * 2004-09-28 2006-03-30 Huiping Zhang Preparation of N-aryl pyridones

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017530104A (ja) * 2014-09-02 2017-10-12 石薬集団中奇制薬技術（石家庄）有限公司 ピラゾロ［３，４−ｃ］ピリジン誘導体

Also Published As

Publication number Publication date
US20070282106A1 (en) 2007-12-06
WO2006036926A2 (en) 2006-04-06
WO2006036926B1 (en) 2007-03-15
US7435821B2 (en) 2008-10-14
EP1805176A2 (en) 2007-07-11
WO2006036926A3 (en) 2007-01-18
NO20071634L (no) 2007-06-21
US7579472B2 (en) 2009-08-25
US20060069119A1 (en) 2006-03-30
US20080009626A1 (en) 2008-01-10
CA2582222A1 (en) 2006-04-06
MX2007003427A (es) 2007-05-10
AU2005289598A1 (en) 2006-04-06
KR20070067176A (ko) 2007-06-27
US7304157B2 (en) 2007-12-04
BRPI0516172A (pt) 2008-08-26
IL182147A0 (en) 2007-07-24

Similar Documents

Publication Publication Date Title
AP1164A (en) Substituted 6,6-hetero-bicyclic derivatives.
EP3398952B1 (en) Synthesis process of ruxolitinib
US7435821B2 (en) Efficient synthesis of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
JP2018199698A (ja) 置換された５−フルオロ−１ｈ−ピラゾロピリジン類を製造するための方法
JP2008514712A (ja) ４，５−ジヒドロ−ピラゾロ［３，４−ｃ］ピリド−２−オン類を製造する方法
HU218488B (hu) Új eljárás imidazo-piridin-származékok előállítására
ES2923278T3 (es) Intermedios útiles para la síntesis de derivados de aminopirimidinas, proceso de preparación del mismo y proceso de preparación de aminopirimidina derivados utilizando los mismos
US20060069085A1 (en) Preparation of 4,5-dihydro-pyrazolo[3,4-c]pyrid-2-ones
WO2011109932A1 (en) Novel process for the manufacture of 5-halogenated-7-azaindoles
PT1879893E (pt) Método de síntese de compostos da 1h-imidaz0[4,5-c]quinolin- 4-amina 1-substituída e intermediários dos mesmos
CZ294957B6 (cs) Způsob přípravy substituované imidazopyridinové sloučeniny
CN110204488A (zh) 一种月桂酰阿立哌唑的制备方法
JP2024509995A (ja) リスジプラムを調製するための方法
CN101068812B (zh) 4,5-二氢-吡唑并[3,4-c]吡啶-2-酮的有效合成
JP2022517411A (ja) テトラヒドロピリドピリミジン類の調製方法
TWI905255B (zh) 新型Rho相關蛋白激酶抑制劑的製備方法和此製備方法中的中間體
CN107108604A (zh) 制备三环内酰胺化合物的方法
US6426417B1 (en) Processes and intermediates useful to make antifolates
KR102502701B1 (ko) 2-(6-니트로피리딘-3-일)-9H-다이피리도[2,3-b；3',4'-d]피롤의 제조 방법
KR101657599B1 (ko) 피롤로[2,3-c]피리딘 유도체 또는 이의 약학적으로 허용가능한 염의 제조방법
WO2022091001A1 (en) Process for preparation of palbociclib
HK40027082A (en) Novel intermediates useful for the synthesis of aminopyrimidine derivatives, process for preparing the same, and process for preparing aminopyrimidine derivatives using the same
US20040039013A1 (en) Process for preparing a substituted imidazopyridine compound
CN112479876A (zh) 氧氮杂环庚烷类螺环化合物、中间体及其制备方法
KR20010035293A (ko) 2,6-디클로로-5-플루오로 니코틴산 유도체의 제조방법

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080925

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080925

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20090113